Am J Transplant, Volume 5, Suppl 3 Archives - Page 146 of 170 - ATC Abstracts

2015 American Transplant Congress
Moderate Rejection Episode of Face Transplant After mTOR Conversion to Preserve Renal Function
R. Barth,¹ B. Bojovic,¹ J. Woodall,¹ M. Uluer,¹ C. Drachenberg,¹ C. Shaffer,¹ N. Kelly,¹ E. Rodriguez,² S. Bartlett.¹
¹University of Maryland School of Medicine, Baltimore; ²New York Medical University, New York City.
Face and hand vascularized composite allografts (VCA) have demonstrated durable graft survivals with conventional immunosuppression but with the appearance of renal dysfunction. Management strategies that…
2015 American Transplant Congress
Glomerulosclerosis Patterns Are Non-Uniform Throughout the KDPI Spectrum With Impact on Biopsy Evaluation of Kidneys for Transplant
M. Jendrisak,¹ K. Mulawa,¹ M. Harmon,¹ D. Cimbaluk.²
¹Gift of Hope Organ & Tissue Donor Network, Itasca, IL; ²Rush University, Chicago, IL.
Background: The kidney donor profile index (KDPI) stratifies kidney quality with direct bearing on organ allocation and utilization. Procurement biopsy is commonly performed and factored…
2015 American Transplant Congress
T-Cell Depletion Versus Interleukin-2 Antagonists in a Kidney Transplant Model of Sensitized Rhesus Macaques
C. Burghuber,^1,2 J. Kwun,¹ E. Page,¹ F. Leopardi,³ A. Gibby,¹ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.¹
¹Emory University, Atlanta, GA; ²Medical University Vienna, Vienna, Austria; ³Duke University, Durham, NC.
[Background] Sensitized patients comprise up to a third of the kidney waiting list. Preformed and newly formed alloantibodies post transplantation (TX) deteriorate graft survival, recall…
2015 American Transplant Congress
Racial Disparities in Access to Kidney Re-Transplantation in the United States
C. Garrett, R. Patzer, R. Zhang, A. Adams.
Surgery, Emory Transplant Center, Atlanta, GA.
Introduction: The number of patients with a failed kidney transplant who are being considered for re-transplantation has steadily increased over the past few years. It…
2015 American Transplant Congress
Utilization and Characteristics of Kidney Donors in the US by OPTN-Defined Increased Risk Donor Status
M. Ison,^1,2 B. Ho,² J. Leventhal,² D. Ladner.²
¹Infectious Diseases, Northwestern University, Chicago; ²Organ Transplantation, Northwestern University, Chicago.
Background: The number of candidates in need of kidney transplantation is far larger than the number of organ donors. To expand the organ pool, there…
2015 American Transplant Congress
Early Hospital Readmission and Distance from Transplant Center
E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 D. Segev.^1,2
¹Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD; ²Epidemiology, Johns Hopkins University, School of Public Health, Baltimore, MD.
Background: Early hospital readmission occurs in 31% of kidney transplant (KT) recipients and may be associated with mechanistic factors not previously captured in patient-level risk…
2015 American Transplant Congress
Incidence and Clinical Severity of Hypogammaglobulinemia (Hypo-IgG) in Highly-HLA Sensitized Patients (HS) Undergoing Desensitization (DES)
A. Vo,¹ S. Ge,² A. Petrosyan,² M. Toyoda,² J. Choi,¹ J. Kahwaji,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
¹Kidney Transplant, Cedars-Sinai Medical Center, LA; ²Transplant Immunology Laboratory, Cedars-Sinai Medical Center, LA, CA.
Introduction: Desensitization therapies (DES) have dramatically improved rates of transplantation among HS patients. However, antibody-reduction and B-cell/plasma cell directed therapies could have implications for humoral…
2015 American Transplant Congress
Impact of Baseline and Postoperative Isoagglutinin Titer on Clinical Outcomes in ABO-Incompatible Living Donor Kidney Transplantation
E. Shin,¹ H. Cho,¹ H. Kim,¹ C. Baeck,¹ H. Yu,¹ D. Han,² S.-K. Park.¹
¹Internal Medicine, Asan Medical Center, Seoul, Republic of Korea; ²General Surgery, Asan Medical Center, Seoul, Republic of Korea.
Background : ABO-incompatible (ABO-i) kidney transplantation (KT) has expanded in consequence of the development of desensitization protocol. However, the impact of baseline and postoperative isoagglutinin…
2015 American Transplant Congress
Induction Therapy With either Anti-Thymocyte Antibodies or Il2 Receptor Inhibitors Appears to Decrease the Risk of Graft Loss in DCD Liver Transplantation Compared to No Induction Therapy
S. Rayhill, J. Haldorson, A. Dick, S. Nazarian, L. Sibulesky, M. Montenovo, L. Yu, I. Javid, T. Pearson, R. Bakthavatsalam, P. Healey, J. Perkins, J. Reyes.
University of Washington, Seattle.
An analysis of our center's outcomes in DCD liver transplants suggested that induction with anti-thymocyte antibody preparations (ATG) may reduce the risk of graft loss…
2015 American Transplant Congress
Impact of Donor Post-Extubation O2 Delivery on Recipient Hypoxic Cholangiopathy in Donation After Circulatory Death Liver Transplantation: The University of Colorado Experience
T. Chirichella,¹ C. Dunham,² M. Zimmerman,⁴ K. Conzen,¹ S. Kelley,³ E. Phelan,¹ T. Steinberg,¹ T. Nydam,¹ T. Bak,¹ I. Kam,¹ M. Wachs.¹
¹Transplant Surgery, University of Colorado Hospital, Aurora, CO; ²Department of Surgery, St. Elizabeth Health Center, Youngstown, OH; ³Donor Alliance Organ Procurement Organization, Denver, CO; ⁴Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI.
The critical shortage of deceased organ donors has led to increased utilization of DCD liver grafts. The purpose of this study was to evaluate DCD…